G. Perez-Chacon
发表
M. T. Vallejo-Cremades,
M. Morado,
R. Castejón,
2016,
PloS one.
A. Green,
F. Al-Shahrour,
E. Rakha,
2021,
bioRxiv.
F. Martín-Saavedra,
S. Ballester,
J. García-Marco,
2004,
Leukemia.
J. Zapata,
I. Melero,
O. Murillo,
2013,
The Journal of Immunology.
Ivan Martinez-Forero,
Juan M. Zapata,
Ignacio Melero,
2013
.
J. Zapata,
G. Pérez-Chacón,
C. de los Ríos,
2014,
Pharmacological research.
J. Zapata,
I. Melero,
I. Martinez-Forero,
2018,
Front. Immunol..
M. Morado,
J. Vargas,
S. Rosado,
2009,
International journal of laboratory hematology.
M. Morado,
J. Vargas,
S. Rosado,
2007,
Leukemia research.
CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients
J. Vargas,
S. Rosado,
I. Losada-Fernández,
2007,
Leukemia & lymphoma.
I. Buño,
J. Zapata,
C. Muñoz‐Calleja,
2015,
Clinical Cancer Research.
J. Zapata,
G. Pérez-Chacón,
G. Perez-Chacon,
2021,
Frontiers in Immunology.
John Calvin Reed,
J. Zapata,
Yongwon Choi,
2014
.
John Calvin Reed,
J. Zapata,
Yongwon Choi,
2012,
The Journal of Immunology.
J. Zapata,
G. Pérez-Chacón,
G. Perez-Chacon,
2012
.
John Calvin Reed,
J. Zapata,
Yongwon Choi,
2012
.
J. Zapata,
G. Pérez-Chacón,
G. Perez-Chacon,
2012
.
J. García-Marco,
J. Vargas,
S. Rosado,
2005,
American journal of clinical pathology.
J. Balsinde,
M. Balboa,
A. Astudillo,
2009
.
J. Zapata,
I. Melero,
L. Álvarez-Vallina,
2018,
Nature Communications.
J. Zapata,
C. Vincent-Fabert,
G. Perez-Chacon,
2021,
Frontiers in Immunology.
John Calvin Reed,
S. Lefebvre,
J. Zapata,
2019,
Front. Immunol..
C. Erausquin,
Í. Rúa-Figueroa,
M. Citores,
2007,
Arthritis research & therapy.
J. Balsinde,
M. Balboa,
D. Balgoma,
2009,
Biochimica et biophysica acta.
J. Balsinde,
M. Balboa,
D. Balgoma,
2011,
The Journal of Biological Chemistry.
C. Rodríguez-Gallego,
M. García-Laorden,
S. Ojeda-Bruno,
2008,
International journal of immunogenetics.
F. Sánchez‐Madrid,
J. Zapata,
C. Muñoz‐Calleja,
2020,
Journal of Hematology & Oncology.
J. Zapata,
C. Muñoz‐Calleja,
A. Beltrán,
2013,
Journal of Hematology & Oncology.
RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer
A. Green,
F. Al-Shahrour,
E. Rakha,
2023,
EMBO molecular medicine.
J. Balsinde,
M. Balboa,
A. Astudillo,
2009,
The Journal of Immunology.
J. Balsinde,
M. Balboa,
D. Balgoma,
2010,
The Journal of Immunology.
J. Balsinde,
M. Balboa,
Carlos Guijas,
2012,
Journal of Lipid Research.
J. Zapata,
I. Melero,
L. Álvarez-Vallina,
2018,
Nature Communications.
J. Zapata,
G. Pérez-Chacón,
G. Garaulet,
2015,
Cancer Gene Therapy.
F. Sánchez‐Madrid,
J. Zapata,
F. Albericio,
2018,
Bioconjugate chemistry.
J. Zapata,
Alicia de la Cruz,
C. Valenzuela,
2017,
Front. Pharmacol..
M. Citores,
S. Mellor-Pita,
S. Rosado,
2008,
Human immunology.
J. Balsinde,
M. Balboa,
D. Balgoma,
2011,
Biochimica et biophysica acta.
F. Mulero,
J. Zapata,
A. Alfranca,
2019,
Cancer Gene Therapy.
J. Balsinde,
M. Balboa,
A. Astudillo,
2009
.
F. Sánchez‐Madrid,
J. Zapata,
F. Albericio,
2020,
ACS omega.
M. Balboa,
D. Balgoma,
A. Pol,
2011,
The Journal of Biological Chemistry.
M. Balboa,
D. Balgoma,
A. Astudillo,
2010,
The Journal of Immunology.
G. Garaulet,
Antonio Rodríguez,
G. Perez-Chacon,
2015,
Cancer Gene Therapy.